Sonoma Orthopedic Products, a US-based, corporate-backed orthopaedic device producer, has raised $12m from growth equity firm First Analysis to support the launch and commercialisation of its new ankle implant product.
The company has now raised just over $60m since it was founded in 2005, including $22m from its last round, a 2011 series D led by Ascension Health Ventures, the corporate venturing unit of healthcare system Ascension Health.
Other past investors in Sonoma include medical device maker Legacy Life Science, Split Rock Partners, EDF Ventures, MedVenture Associates, DFJ InCube Ventures, Emergent Medical Partners and Asset Management Partners.
Sonoma makes implants for wrist, ankle, and collarbone fractures that can be inserted into a canal in the centre of the bone. The company plans to launch its ankle-focused product once it obtains clearance from the US Food and Drug Administration.